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ThE GIST of IT: KIT And PdGfRa MUTATIon TESTInG 
foR GIST PATIEnTS
Babb C, Schnugh d, Willem P
Gastro-intestinal stromal tumour (GIST) is the most common 
mesenchymal tumour of the gastro-intestinal tract. Since the 
introduction of tyrosine kinase inhibitors (TKIs), such as Gleevec®, 
the treatment of these patients has improved dramatically. 
Heterogenic mutations in the KIT and PDGFRa genes are central 
to the pathogenesis of GIST. The presence of these mutations is 
the rationale for TKI therapy. Previous studies in other regions of 
the world have shown that the commonest mutation occurs in KIT 
exon 11 and varies from substitutions to deletions to insertions. 
Most of these mutations indicate that the patient will respond well 
to Gleevec® therapy. Another common mutation, represented by a 
duplication in KIT exon 9, is an indicator that the patient requires 
a double dose of Gleevec® to get a similar response to, if not the 
same as, patients who have a KIT exon 11 mutation. The test has 
been established at the Somatic Cell Genetics Unit, Department of 
Haematology and Molecular Medicine, National Health Laboratory 
Service, providing this key service to treating physicians in South 
Africa.
DNA was extracted from paraffin-embedded resected tumour 
specimens, and gene-specific exons were amplified by the 
polymerase chain reaction (PCR). Mutational screening of exons in 
the KIT and PDGFRa genes was done by direct sequencing of the 
PCR products. As there are a number of exons (21 in total) to be 
screened, a priority list, based on previously reported frequency of 
exon mutations, was determined to shorten the turnaround time. 
A total of 17 GIST tumour biopsies from South African patients 
have been tested. They include a sample from a juvenile boy and 
a patient suffering from neurofibromatosis 1 (NF1). There were 8 
females and 9 males, and the median age (excluding the 14-year-
old) was 58 years. The most common site of disease was the 
stomach. Mutations were mainly detected in KIT exon 11, with 7 
deletions, 1 deletion-insertion and 4 substitutions, most frequently 
affecting codons 557 - 560. The remaining mutation detected was 
a deletion in PDGFRa exon 18. Four patients had no detectable 
mutations in the exons screened and were considered to have 
wild-type disease. These included the juvenile and the NF1 patient, 
which is in keeping with what is generally observed in these 
GIST patients. One unknown and 4 known silent polymorphisms 
were observed within the exons sequenced. This was not 
surprising, as black African populations are known to have more 
polymorphisms. 
The mutational screening of KIT and PDGFRa genes informs 
treatment decisions for GIST patients. With this test now available 
in South Africa, the management of patients with this rare disease 
can improve significantly. The trend of mutations observed in this 
preliminary study in Africa predicts that patients should respond 
well to Gleevec® therapy. This study establishes baseline data on 
the molecular profile of GIST in a South African population. 
ThE EffICACy of PRofoUnd ACId InhIBITIon WITh 
ESoMEPRAzolE 40 MG Bd To REvERSE C-MyB MRnA 
ovER-ExPRESSIon In PATIEnTS WITh BARRETT’S 
oESoPhAGUS
Marais M, Kidd M, Abbas z, Parker I M, Kotze M J,  
van Rensburg C J
Background: The role of c-myb mRNA expression in Barrett’s 
oesophagus has been elucidated and demonstrates a progressive 
and significant increase in histopathologically worse tissue type. 
Currently life-long proton pump inhibition is recommended, but 
data to support the effectiveness of this practice are lacking and 
mostly indirect.
Aim: To study the efficacy of 3 months’ profound acid inhibition 
(esomeprazole 40 mg bd) in reversing c-myb mRNA over-
expression in patients with Barrett’s oesophagus. 
Subjects and methods: Seventeen patients (12 males, 5 females, 
mean age 63 years, BMI 27.7) with histologically confirmed 
Barrett’s oesophagus were treated with esopmeprazole 40 mg bd 
for 12 weeks. Oesophageal biopsies were obtained pre-treatment 
from both the Barrett’s epithelium and the adjacent normal 
squamous mucosa and repeated after 3 months’ treatment. C-myb 
mRNA expression was determined by RT-PCR. Statistical analysis 
was performed using one-way analysis of variance, the chi-square, 
Kruskal-Wallis and Mann-Whitney tests and the nominal p-value. 
Results: Pre-treatment there was a statistically significant difference 
in c-myb mRNA expression between the Barrett’s and the normal 
squamous epithelium (p=0.01). There was a statistically significant 
decrease in c-myb mRNA expression after 3 months’ treatment in 
the Barrett’s epithelium (p=0.02), but this was not observed in the 
normal squamous epithelium.
Conclusion: The c-myb mRNA expression significantly decreased 
after 3 months’ treatment with esomeprazole 40 mg bd. This 
change was not observed in the normal squamous epithelium.
STUdy of oESoPhAGEAl STRICTURE dIlATATIon AT 
nElSon MAndElA ACAdEMIC hoSPITAl
Bhattarai P R
Background: Oesophageal strictures are common in the Transkei 
region, which is known for its high incidence of oesophageal 
carcinoma. The majority of strictures are caused by malignant 
disease, with more than a third of patients who are scoped 
requiring palliative dilatation. Patients with oesophageal strictures 
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present in a poor general condition, and perforation of the 
oesophagus in such cases makes the prognosis even worse. 
Aim: To review all cases of oesophageal dilatation and attempt to 
correlate oesophageal perforation with different procedures and 
patient disease factors. 
Methods: All patients with oesophageal strictures who underwent 
dilatation in the Department of Surgery from November 2008 to 
April 2010 were included in this study. Data were recorded at 
the time of the procedure and patients were followed up in the 
ward until discharge or death. Patients were dilated either using 
a balloon dilator through a flexible scope or with Savary Gillard 
dilators through a rigid oesophagoscope. 
Results: A total of 242 procedures were done in 218 patients over 
the study period (126 males and 116 females, age range 22 - 103 
years, mean age 62.6 years, 24 procedures for benign and 218 for 
malignant strictures; 59 patients underwent Savory Gillard dilation 
through a rigid oesophagoscope and 183 dilations were done with 
a balloon dilator through a flexible scope). A total of 5 perforations 
occurred, 1 for 24 benign oesophageal strictures and 4 for 218 
malignant oesophageal strictures. 
Conclusions: Oesophageal dilatation is a safe procedure with good 
palliation in a resource-limited area.
Category: liver
hEPATIC TB-ASSoCIATEd IRIS CoMPAREd WITh 
AnTIRETRovIRAl-nAIvE hIv PoSITIvE PATIEnTS WITh 
hEPATIC TB
Sonderup M, hairwadzi h, Spearman W, Wainwright h
Introduction: The immune reconstitution inflammatory syndrome 
(IRIS) is an important early complication of antiretroviral therapy 
(ART) in resource-limited settings, particularly in patients with TB. 
IRIS is a consequence of the rapid restoration of pathogen-specific 
immune responses to opportunistic infections causing deterioration 
in treated infection or a new presentation of subclinical infection. 
Few data exist regarding the clinical and pathological features 
of patients with hepatic manifestations of TB IRIS and how this 
compares with ART-naïve HIV/AIDS patients with liver TB, or on 
what features suggest IRIS as the reason for the liver disease.
Methods: Patients who had undergone liver biopsy and fulfilled 
consensus definitions for TB IRIS were retrospectively selected. A 
control group of ART-naïve patients with liver TB were selected. 
All biopsies were performed using a standard needle biopsy set. 
Clinical data were obtained from patient records and liver biopsies 
were assessed blindly. 
Results: 22 patients in the TB IRIS and 11 in the TB liver group 
were evaluated (mean age 31.8±4.9 and 36.2±13.3 years, p=0.2). The 
pre-ART median CD4 count was 34 cells/µl (8 - 175) in the TB IRIS 
group and 61 (17 - 118) in the ART-naïve TB liver group (p=0.08). In 
the TB IRIS group the median change in CD4 count from the lowest 
pre-ART nadir was 115 (36 - 344), while the median duration of 
ART was 30 (14 - 71) days before presentation. In the TB IRIS group 
all presented with hepatomegaly. The median ALT, AST and ALP 
values were not significantly different between the two groups, but 
GGT was higher in the TB IRIS (1 004, range 190 - 2 161) than in 
the TB liver group (313, range 167 - 1 483) (p=0.007). Histological 
examination revealed significantly more granulomas per liver core 
in the TB IRIS group than in the TB liver group (26 (4 - 111) v. 7  
(3 - 25), p=0.006). Associated with the granulomas, eosinophils 
were observed more frequently in the TB IRIS group than in the TB 
liver group (86% v. 27%, respectively).
Conclusion: Hepatic TB IRIS occurs early in the course of ART. 
Features suggesting IRIS include hepatomegaly, rapid CD4 increase 
and a significantly elevated GGT. Histologically suggestive features 
include the presence of numerous granulomas with an eosinophilic 
inflammatory component.
AzAThIoPRInE- oR 6-MERCAPToPURInE-ASSoCIATEd 
hEPAToToxICITy dIMInIShES UPon AdMInISTRATIon 
of 6-ThIoGUAnInE In IBd PATIEnTS
van Asseldonk d, Mulder C J, van Bodegraven A A
Aim: A skewed metabolism with subsequently high levels of 
6-methylmercaptopurine nucleotides (6-MMP) upon administration 
of azathioprine or 6-mercaptopurine has previously been related to 
hepatotoxicity. We hypothesised that 6-thioguanine (6-TG) therapy, 
which is not accompanied by the formation of these 6-MMP, could 
ameliorate or avoid hepatotoxicity.
Materials and methods: From a cohort of IBD patients which has 
been treated with 6-TG, patients who previously failed AZA or 
6-MP as a result of a skewed metabolism were selected. Laboratory 
test- and therapy-specific data were collected at baseline and 
during follow-up.
Results: Eleven patients (3 males) with a mean age of 50.2 (SD 12.6) 
years were included in the analysis. Five had Crohn’s disease and 
6 had ulcerative colitis. Just before initiation of 6-TG the median 
6-MMP/6-TGN ratio was 48 (19 - 124). Median 6-TG dosage was 
21 mg (range 10 - 24) daily and the median time to follow-up 
was 2.5 months (1.4 - 18.2). At follow-up 2 out of 11 had liver test 
abnormalities compared with 8 out of 11 at baseline (p=0.014). 
Mean ALAT and ASAT concentrations decreased from 34 to 22 
U/l (p=0.038) and 75 to 27 U/l (p=0.014), respectively. The median 
6-TGN concentration was 300 pmol/8x108 RBC (170 - 830) at 
baseline, whereas at follow-up it was 1 070 (390 - 2 100) (p=0.001). 
Both at baseline and during follow-up all but one of the patients 
were in clinical remission.
Conclusion: Hepatotoxicity associated with skewed thiopurine 
metabolism is reduced in IBD patients given 6-TG. This may be 
because 6-TG administration does not cause MMP formation.
BACTERIAl TRAnSloCATIon, ThE CAUSE of ACTIvATEd 
InTESTInAl MACRoPhAGES In dECoMPEnSATEd lIvER 
dISEASE
du Plessis J, Becker J h R, Cassol E, Malfelt S, niewoudt M, 
Potgieter f, Roos l, Slavik T, Ter haar Sieve droste J,  
van Beljon J I, van der Merwe S W
Background: Bacterial infections are a well-described complication 
in chronic liver disease (CLD). In fact the decompensation of liver 
functions can occur as a result of bacterial products and DNA. 
However, the exact mechanism of bacterial translocation (BT) is 
unknown.
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Aim: To study the role of epithelial barrier and innate immune 
response in BT associated with CLD.
Materials and methods: Decompensated CLD (N=38) patients and 
controls (N=9) were included. Plasma LPS levels were determined. 
At endoscopy duodenal biopsies were obtained for histology, 
electron microscopy, macrophage and RNA isolation. Flow 
cytometry on isolated macrophages as well as qRT-PCR on total 
RNA were performed. 
Results: Plasma LPS levels were elevated in decompensated CLD. 
EM showed intact epithelial barriers and tight junctions in both 
CLD patients and controls. FACS showed that isolated intestinal 
macrophages in CLD were activated (CD14+, Trem+, CD80+, 
CD86+). 11 genes including IL-8, NOSII, CXCL1, CXCL6, CCL13 as 
well as TLR1 and TLR6 were found to be up-regulated in CLD.
discussion: BT leads to decompensation of liver function in CLD. 
The importance of BT is reflected in elevated plasma levels of LPS 
in CLD. Isolated intestinal macrophages in CLD but not in controls 
were activated (CD14+), confirming recruitment of circulatory 
monocytes. The upregulation of IL-8 and other chemokines is likely 
to result from the interaction of bacterial products with TLR 1 and 
6 on epithelial cells. Furthermore, NOSII was upregulated and 
has been shown to disrupt epithelial barrier function, which may 
directly impact on BT. This study showed that activated intestinal 
macrophages may play a key role in BT in CLD. 
lIvER hISToloGy of IBd PATIEnTS Who ARE 
TREATEd WITh 6-ThIoGUAnInE dUE To fAIlURE of 
ConvEnTIonAl ThIoPURInES REvEAlS vERy fEW 
CASES of nodUlAR REGEnERATIvE hyPERPlASIA
van Asseldonk d P, Bloemena E, de Boer n K h, den hartog G, 
Engels l G J B, Jharap B, Kolkman J J, Mulder C J,  
van Bodegraven A A, Westerveld B d, zondervan P E
Aim: The aim of this study was to assess short-term hepatotoxicity 
of 6-TG therapy in a large population of IBD patients previously 
failing conventional thiopurines.
Materials and methods: A cross-sectional multi-centre cohort 
study was performed including IBD patients treated with 6-TG 
for at least 6 months and who underwent a liver biopsy for safety 
assessment. The liver specimens were stained with H&E, trichrome 
and reticuline and were scored by experienced liver pathologists.
Results: Liver biopsy specimens were obtained from 99 patients 
with a mean age of 43.8 years (SD 12.0). Thirty-six patients were 
male. All but 2 patients were pretreated with azathioprine and/
or 6-mercaptopurine. Mean 6-TG dose was 0.28 mg/kg (SD 0.07) 
and median 6-TG treatment duration, from initiation up to the first 
liver biopsy, 25 months (range 6 - 65). Liver histology revealed no 
abnormalities in 51 specimens (51.5%), mild steatosis in 14 (14.1%), 
mild fibrosis in 3 (3.0%), severe steatosis in 2 (2.0%), steatohepatitis 
in 2 (2.0%), sinus dilatation in 8 (8.1%), cholangitis/PSC in 4 (4.0%), 
a specific regeneration in 11 (11.1%), and nodular regenerative 
hyperplasia (NRH) in 4 (4.0%).
Conclusion: NRH (4%) is an uncommon finding in IBD patients 
who had been failing conventional thiopurine therapy and were 
subsequently treated with 6-TG. This is in contrast to some 
previous studies (up to 62%), but corresponds with the prevalence 
of NRH in thiopurine-naïve IBD patients (6%). 
RISK fACToRS foR EARly REBlEEdInG And dEATh 
In AlCoholIC CIRRhoTIC PATIEnTS WITh ACUTE 
vARICEAl hAEMoRRhAGE TREATEd WITh EMERGEnCy 
EndoSCoPIC InJECTIon SClERoThERAPy
Chinnery G, Bornman P C, distiller G, Kotze U K, Krige J E J
Background: Bleeding from oesophageal varices is a leading cause 
of death in alcoholic cirrhosis. Recurrent bleeding and subsequent 
progressive liver failure result in significant morbidity and 
mortality. 
Aims: Identification of risk factors for early rebleeding and death 
at 6 weeks after endoscopic injection sclerotherapy.
Methods: A retrospective evaluation was performed on a 
prospectively collected database of 310 consecutive alcoholic 
cirrhotic patients with AVH treated at a single centre to identify 
risk factors related to rebleeding and death within 6 weeks of 
initial treatment. 
Results: 310 alcoholic cirrhotic patients with AVH underwent 
786 endoscopic variceal injection treatments (342 emergency, 444 
elective) during 919 endoscopy sessions in the 6 weeks after their 
first variceal bleed. Sclerotherapy controlled initial AVH in 304 
patients (98%). 75 (24.2%) patients rebled. Of 15 variables studied, 
bilirubin levels >51 mmol/l and >6 units of blood transfused 
during initial hospital admission were predictors of variceal 
rebleeding. Mortality increased exponentially as the Child-Pugh 
score increased. Encephalopathy, ascites, bilirubin levels >51 
mmol/l, INR >2.3, albumin <2.5 mg/dl and the need for balloon 
tube tamponade were predictors of death within the first 6 weeks.
Conclusion: Endoscopic sclerotherapy controls acute oesophageal 
variceal bleeding in most alcoholic cirrhotic patients, with a 
rebleeding rate of 24.2%. At 6 weeks overall survival was 75.2%. 
Most deaths occur in Child-Pugh grade C patients. Patients with 
AVH and encephalopathy, ascites, bilirubin levels >51 mmol/l, 
INR >2.3, albumin <2.5 mg/dl and who require balloon tube 
tamponade are at increased risk of dying within the first 6 weeks. 
Category: hepato-biliary
MAlIGnAnT BIlIARy oBSTRUCTIon: A PRoSPECTIvE 
RAndoMISEd TRIAl CoMPARInG PlASTIC And METAl 
STEnTS foR PAllIATIon of SyMPToMATIC JAUndICE
Bernon M, Bornman P C, Burmeister S, Krige J E J , Shaw J M
Background: Both plastic and self-expanding metal stents (SEMS) 
have been used to relieve jaundice in patients with advanced 
malignant biliary obstruction. This study compared the clinical 
efficacy of plastic versus metal biliary stents.
Materials and methods: In a prospective randomised controlled 
trial 22 patients with malignant common bile duct obstruction not 
amenable to curative resection were offered palliative stenting from 
November 2008 to March 2010 and were followed up until death. 
Data were collected prospectively. We compared patient survival 
and stent patency rates.
Results: 12 patients received 10 Fr plastic stents and 10 patients 
received expandable metal stents. Mean duration of hospital 
stay after stenting for both groups was 2 days (range 1 - 2 days). 
Jaundice was relieved in all patients. Two patients with metal 
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stents required subsequent intervention at 8 and 21 days: one stent 
blocked due to a bile duct stone, and another migrated proximally 
and was replaced. Plastic stents in 6 patients blocked at a mean of 
7 months (range 3 - 18 months) In the metal stent group 2 patients 
required re-admission twice to hospital (total 32 days) compared 
with the plastic group in which 5 patients required a total of 36 
days in hospital. Mean survival was 173 days compared with 192 
days.
Conclusion: Compared with SEMS, plastic 10 Fr biliary stents 
blocked more frequently, were replaced more often and required 
more hospital admissions but necessitated a similar total number 
of days in hospital after placement. These preliminary data suggest 
only a marginal advantage for palliative metal stenting.
CoMBInEd PAllIATIvE STEnTInG foR MAlIGnAnT 
BIlIARy And dUodEnAl oBSTRUCTIon
Price C, Beningfield S J, Bornman P C, Burmeister S,  
Krige J E J, Shaw J M
Background: Biliary and duodenal stenting provides effective 
palliation for patients who have malignant biliary or duodenal 
obstruction. This study evaluated the clinical efficacy of combined 
palliative stenting in patients with advanced biliary and duodenal 
malignant obstruction. 
Patients and methods: Consecutive patients with advanced 
biliary and duodenal malignant obstruction not suitable for 
surgical bypass referred for palliative duodenal stenting 
using self-expanding metal stents (SEMS) and biliary stenting 
using either SEMS or 10 or 12 Fr plastic stents were followed 
prospectively from January 2009 to March 2010. Stenting was 
performed under fluoroscopic guidance and conscious sedation. 
Percutaneous transhepatic stenting was used when initial 
endoscopic biliary access was not technically possible. Data were 
collected prospectively. Demographic data, nature of the malignant 
stricture, stent deployment success rates, stent patency, procedural 
complications and survival times were recorded. 
Results: Forty-two patients (pancreatic carcinoma N=31; 
cholangiocarcinoma N=4; gallbladder carcinoma N=3; antral 
gastric carcinoma N=4) underwent double stenting. In 40 patients 
the biliary obstruction occurred before the onset of duodenal 
obstruction, and in 2 patients the duodenal obstruction preceded 
biliary obstruction. The mean pre-stenting bilirubin level was 297 
µmol/l and the gastric outlet obstruction severity score (GOOSS) 
0. Duodenal stenting was successful in all 42 patients; in 3, oral 
intake after stenting was inadequate. Endoscopic biliary stents 
were placed in 33 patients (SEMS N=29, plastic N=4) and 9 biliary 
stents were inserted using radiological percutaneous transhepatic 
biliary access (SEMS N=7, plastic N=2). Mean hospital stay for each 
procedure after stenting was 3.8 days. The functional success rate 
with relief of jaundice was 95% (40/42) and 93% of patients (39/42) 
had improved GOOSS scores. Complications occurred in 3 patients 
with duodenal stents (GI bleeding in 2, stent migration in 1). 
During follow-up, 5 duodenal stents and 5 biliary stents blocked. 
The median survival after combined stenting was 85.2 days (range 
4 - 320 days). 
Conclusion: Biliary and duodenal stenting is safe and effective 
in malignant biliary and duodenal obstruction and provides 
effective palliation in patients with advanced malignancy who are 
unsuitable for bypass surgery and have limited life expectancy.
Category: Small bowel/inflammatory bowel
AUToloGoUS STEM CEll TRAnSPlAnTATIon In 
REfRACToRy CoElIAC dISEASE TyPE II PATIEnTS 
UnRESPonSIvE To ClAdRIBInE ThERAPy
Tack G, Al-Toma A, huijgens P C, Machado M v, Mulder C J J , 
ossenkoppele f P G J, Schreurs M W J, Schmittel A, verbeek W 
h M, visser o J, Wondergem M J
Background: Autologous haematopoietic stem cell transplantation 
(auSCT) is used for T-cell eradication in both malignant and 
immunological diseases. It seems feasible and safe for refractory 
coeliac disease (RCD) type II on the basis of short-term follow-up, 
although long-term results have not been evaluated yet. Transition 
into enteropathy-associated T-cell lymphoma (EATL) occurs in 60 - 
80% of cases, with a high mortality rate. It is therefore important to 
evaluate new treatment strategies. 
Methods: Between March 2004 and February 2010, we 
intended to treat 18 RCD II patients with auSCT preceded by 
conditioning with fludarabine and melphalan, as a consequence of 
unresponsiveness to cladribine therapy. Adverse events, survival 
rate, EATL development, and change in clinical, histological and 
immunological course were monitored.
Results: Thirteen patients were transplanted successfully and 
followed for >2 years. Three of them died. The 4-year survival rate 
was 66%. The majority showed an impressive clinical improvement 
and 5 complete histological remission. In 6 patients auSCT could 
not be performed; they all died with a median survival of 5.5 
months. EATL was observed in 1 transplanted patient, only after 4 
years of follow-up.
Conclusion: AuSCT after conditioning with high-dose 
chemotherapy in RCD II patients unresponsive to cladribine 
therapy is feasible, and seems promising.
MoRTAlITy In An IBd CohoRT fRoM CAPE ToWn
Epstein d, levin d, Watson l K, Watermeyer G
No mortality data on inflammatory bowel disease (IBD) patients 
from South Africa have been published. Controlled population-
based studies from the developed world have not consistently 
shown that IBD causes premature death. 
A retrospective analysis of all IBD patients on the Groote Schuur 
Hospital (GSH) IBD database was conducted. Patient deaths were 
identified on the GSH Clinicom System and IBD patient death 
notifications were also checked on Ancestry24. 
Clinical record review was performed and cause of death 
categorised as: 
1. IBD related 
2. Non-IBD cancer
3. Other cause of death
4. Unknown.
Results: 1 464 patients with IBD were reviewed, consisting of 690 
patients with Crohn’s disease (47%) and 774 with ulcerative colitis 
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and indeterminate colitis (53%). 84 (5.7%) deaths were recorded. 
In the ulcerative colitis group, 13 deaths were IBD related, 5 due 
to non-IBD cancer, 4 due to other causes and 19 due to unknown 
causes. In the Crohn’s disease group the respective figures were 
12, 1, 4 and 25. The IBD-related deaths were due to IBD cancer (6), 
peri-operative (15), PSC related (3) and due to long-term TPN (1).
Conclusion: This is the first retrospective analysis of IBD-related 
mortality from southern Africa.
PREGnAnCy WEIGhT GAIn And BIRTh oUTCoME By 
nUTRITIon EdUCATIon
Jahan K
Rationale and objectives: About 35% of babies born in Bangladesh 
are of low birth weight (LBW). The objective was to assess the 
effect of nutrition counselling on reduction in LBW and increase in 
weight gain during pregnancy. 
Materials and methods: 300 pregnant women in the 3rd trimester 
were randomly allocated to a control group or an intervention 
group that received education on food security, disease control and 
care, and appropriate breastfeeding of the newborn. 
Results and findings: The mean weight gain of pregnant women 
was higher in intervention group compared with controls (8.58 kg 
v. 6.08 kg; p<0.001). The prevalence of LBW was significantly lower 
in the intervention group compared with the control group (0% 
v. 53.3%). Early initiation of breastfeeding was also higher in the 
intervention group (71% v. 7.3%; p<0.001). 
Conclusion: This study demonstrated that nutrition education can 
effectively reduce low birth weight.
Category: Colorectal
doUBlE vERSUS SInGlE SAMPlInG of fAECAl 
IMMUnoChEMICAl TESTS foR ColoRECTAl CAnCER 
SCREEnInG: AddEd vAlUE oR AddEd CoSTS?
van Turenhout S T, Ben larbi I B, Bouman A A, Coupé v M h, 
Kanis S, Meijer G A, Mulder C J J, oort f A, van der hulst R W 
M, van hengel E, Wesdorp I C E
Background: Faecal immunochemical tests (FITs) are widely used 
in colorectal cancer (CRC) screening and have relatively good 
performance. Yet, as sensitivity is well below 100%, there is room 
for improvement. The aim of the present study was to investigate 
whether FIT sampling from bowel movements on 2 consecutive 
days can improve sensitivity without substantially affecting 
specificity. 
Methods: In subjects scheduled for colonoscopy, test performance 
of single FIT sampling was compared with 2-day FIT sampling. 
Double FIT sampling was considered positive if one or both 
FITs was higher than the cut-off value. Test performances 
were evaluated at cut-off values ranging from 50 to 150 ng/ml 
(incremental steps of 25 ng/ml).
Results: Of 1 096 subjects who performed two FITs and underwent 
total colonoscopy, 124 (11.3%) had screening relevant neoplasia, 
of which 20 were CRC stage I or II and 104 were advanced 
adenomas. Positivity rates for single FIT ranged from 10% to 16%, 
and for double FIT from 12% to 21%. At the same cut-off value 
for positivity, sensitivity of double FIT sampling was higher than 
sensitivity of single FIT sampling. For any particular specificity 
(e.g. 90%), the sensitivity of double FIT was slightly higher (52%, 
cut-off 100 ng/ml) than that of single FIT (46%, cut-off 75 ng/ml) 
at a lower cut-off value, but these differences were not statistically 
significant.
Conclusions: Two-fold sampling of FIT increases sensitivity for 
advanced neoplasia. However, at a given specificity, sensitivity of 
double sampling is comparable to single sampling at a lower cut-
off value.
A PRoSPECTIvE STUdy of CLOSTRIDIUM DIFFICILE-
ASSoCIATEd dIARRhoEA AT A TERTIARy REfERRAl 
hoSPITAl In SoUTh AfRICA
Rajabally n, Mendelson M, oliver S, Pentecost M,  
Pretorius G, Watermeyer G, Whitelaw A
objective: To report the incidence of CDAD at GSH, identify risk 
factors, assess patient outcomes and determine the presence of 
NAP1.
Methods: Adult patients with diarrhoea seen over 15 months were 
included prospectively. Stools were tested for C. difficile toxin A 
using standard EIA. Positive specimens were evaluated for NAP1 
by real-time PCR.
Results: 653 stools were analysed; complete data were available for 
645. CDAD was diagnosed in 60 patients (9.3%); their median age 
was 36 years (IQR 30 - 56), and 57% were female. Fifty-two (87%) 
tested toxin positive. The remainder had pseudomembranous 
colitis at endoscopy or surgery. Forty-seven (78%) were 
nosocomially acquired, of which 1 was identified with NAP1. 
Seven (12%) CDAD patients required colectomy, and none was 
NAP1 positive. Forty (67%) CDAD cases had recent antibiotic 
exposure, and 28 (47%) had previously been hospitalised. On 
regression analysis, previous antibiotic use (OR 2.85, 95% CI 1.61 - 
5.03, p<0.0001) and previous admission (OR 1.78, 95% CI 1.02 - 3.1, 
p=0.04) were the only independent risk factors for CDAD. Twelve 
patients (20%) died, none of the deaths being related to CDAD. 
Of the 13 (22%) patients with community-acquired C. difficile 
(CA-CDAD), 10 (77%) had IBD, and 11 (85%) had had no recent 
antibiotic exposure. On multivariate analysis, only IBD was found 
to be an independent risk factor for CA-CDAD (OR 12.08; 95% CI 
1.63 - 89.7, p=0.015). 
Conclusion: The incidence of CDAD at GSH is lower than reported 
in the West. NAP1 currently has little impact. One-fifth of cases 
were community-acquired and not associated with recent antibiotic 
exposure. Patients with IBD have a significantly higher risk of 
CA-CDAD.
MISMATCh REPAIR GEnE MUTATIonS In ColoRECTAl 
CAnCER PATIEnTS In A loW-InCIdEnCE AREA
vergouwe f, Algar U, Boutall A, Goldberg P A,  
Govender A d, Ramesar R, Stupart d, van der linde G d
Introduction: In a previous study we identified 206 patients with 
colorectal adenocarcinoma in the Northern Cape province of 
South Africa, diagnosed between January 2002 and February 2009. 
The age-standardised incidence was 4.2/100 000 per year world 
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standard population. This is 10% of the rate reported in First-World 
countries. In high-incidence areas, the rate of abnormal mismatch 
repair gene expression in colorectal cancers is 5 - 10%. The aim of 
this study is to determine the prevalence of hMLH1- and hMSH2-
deficient colorectal cancer in the Northern Cape.
Methods: Formalin-fixed paraffin blocks of tumours from 77 
colorectal adenocarcinomas identified in the previous study were 
retrieved. Standard immunohistochemical staining methods were 
used to detect the expression of hMLH1 and hMSH2 gene products 
in the tumours.
Results: In 4 patients the immunohistochemistry staining failed, 
leaving 73 cases for analysis. 57 patients had evidence of both 
hMLH1 and hMSH2 gene product. In 10 cases hMLH1 gene 
product was deficient, and in 6 cases hMSH2 gene product was 
deficient. Overall, 16/73 (22%) of cancers were deficient for 
mismatch repair gene products.
Conclusion: In a low-incidence area for colorectal cancer, we found 
22% of colorectal cancers to be mismatch repair gene product 
deficient. This is approximately four times the reported rate in 
high-incidence areas.
Category: diagnostic/therapeutic
ThE RolE of EndoSCoPIC UlTRASoUnd In 
ThE dIAGnoSIS of ISolATEd ABdoMInAl 
lyMPhAdEnoPAThy In hIv-InfECTEd IndIvIdUAlS
van der Merwe S W, Corcoran C, lameris R, Rossouw T, Slavik T 
Background and study aims: Isolated abdominal 
lymphadenopathy poses a major diagnostic challenge, especially 
in HIV-infected patients. In this study we aimed to evaluate the 
value of endoscopic ultrasound and EUS-FNA in the diagnosis of 
abdominal lymphadenopathy. 
Methods: HIV+ patients were screened for abdominal 
lymphadenopathy by echo/CT and included if no diagnosis 
could be made by any other diagnostic method. EUS-FNA was 
performed on an outpatient basis under conscious sedation. The 
fine-needle aspirate was collected for cytology, culture, flow 
cytometry and DNA isolation for PCR. 
Results: A total of 11 HIV+ patients (mean age 35.7, 45% 
males) with a mean CD4+ count of 140.4 and abdominal 
lymphadenopathy were included in the study. Most common 
symptoms were fever and weight loss (both 82%). The appearance 
of necrotic nodes and a yellow aspirate predicted the presence of 
tuberculosis. 7/11 patients were positive for mycobacterium, 1/11 
for lymphoma, 2 had reactive nodes and 1 had a subdiaphragmatic 
fluid collection. One patient was diagnosed with resistant MTB and 
2 patients with M. avium intracellulare, of whom one had a MTB 
co-infection. Cytology diagnosed TB in 2/7 cases. 
Conclusion: EUS-FNA combined with PCR in addition to standard 
tissue evaluation is a safe, minimally invasive and highly accurate 
diagnostic method in the evaluation of isolated lymphadenopthy of 
unknown origin in HIV-infected patients.
A PRoSPECTIvE AUdIT of dIAGnoSTIC lAPARoSCoPy 
In ThE dIAGnoSIS of ABdoMInAl TUBERCUloSIS
Islam J, Clarke d, dawood h, Thomson S R, Wilson d
Introduction: HIV/AIDS has resulted in a resurgence of abdominal 
tuberculosis in South Africa. The role of laparoscopy in making the 
diagnosis is undefined. 
Method: All patients with clinically and radiologically suspected 
but histologically or microbiologically unconfirmed abdominal TB 
were referred to the investigating team for laparoscopy. 
Results: From January 2008 to January 2010, 166 patients were 
referred to us. Forty-eight patients were not fit for laparoscopy. 
Forty-two patients required emergency laparotomy either for 
bowel obstruction or peritonitis. Seventy-six patients underwent 
diagnostic laparoscopy, and 64 of them were HIV positive. 
Laparoscopic findings included intra-abdominal lymphadenopathy 
in 53 patients, minimal ascitic fluid in 51, intra-abdominal mass 
in 13, and deposits on bowel wall, peritoneum or omentum in 
15. In 10 patients (13.15%) an alternative diagnosis was found 
(appendicitis, adenocarcinoma, lymphoma). Forty-nine patients 
(64.47%) had positive histology for TB. In 17 patients (22.36%) 
histological examination revealed nonspecific inflammation and 
reactive lymph nodes. All but 1 of the deposits biopsied were 
positive for TB (14/15). The masses biopsied were positive in 85% 
(11/13) of cases and the lymph nodes were positive in 68% (36/53) 
of cases. Ascitic fluid culture was positive in 35% (8/23) cases. 
Conclusion: Laparoscopy is very useful to diagnose alternative 
surgical pathology. Histology obtained at laparoscopy confirms the 
presence of TB in 65% of cases, which means all the patients with 
clinical and radiological evidence of TB abdomen do not actually 
have TB in the presence of HIV infection.
oUTCoME of EMERGEnCy lAPARoToMy foR 
ABdoMInAl TUBERCUloSIS In A SInGlE SURGICAl 
UnIT
Islam J, Clarke d l, Thomson S R
Introduction: The rising incidence of HIV/AIDS has resulted in a 
resurgence of abdominal tuberculosis (TB) in South Africa. These 
often debilitated patients not infrequently present with acute 
complications requiring surgery. 
Methods and patients: From January 2008 to April 2009, 49 
patients who had positive histology for TB went for emergency 
laparotomy. Twenty-five were male and the mean age was 32 years. 
Thirty-nine were HIV positive, and HIV status of the others was 
unknown or negative.
Results: Only 6 patients had a prior CT abdomen. Twelve patients 
presented with obstruction, 9 with perforation and 28 with 
peritonitis without free air. Intra-operative findings were: frozen 
abdomen in 10 patients, bowel perforations in 13, enlarged lymph 
nodes and ileo-caecal mass in 19 and obstructed small bowel in 
7. Eleven patients (22%) had small-bowel resection and 8 patients 
(16%) had right hemicolectomies. Eighteen patients (37%) ended 
up with stomas (16 ileostomies and 2 colostomies) and only 2 had 
primary anastomoses. Fourteen patients (29%) had relaparotomies 
and 17 (35%) were admitted to the ICU. Twenty-three patients 
(47%) required blood transfusion and 15 (31%) required total 
parenteral nutrition. Three patients developed enterocutaneous 
fistula and 5 were discharged with ventral hernia. Eighteen 
patients died (37%), of whom only 6 had bowel resection, and 10 of 
them were admitted to the ICU. 
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Conclusion: Emergency surgery for TB of the abdomen is 
associated with high morbidity and mortality with high rates of 
ICU admission and prolonged hospital stay, which could have been 
avoided by diagnostic laparoscopy.
CRohn’S dISEASE, hlA B27 And SMAll-dUCT PSC In 
BlACK SoUTh AfRICAn WoMEn: 2 CASES
Buchel o, Bosch f J, Grundling h de K
Introduction: Crohn’s disease is rare in black South Africans (0.3 
per 100 000 incidence annually). HLA B27 is often associated with 
axial arthropathy in patients with Crohn’s disease but is similarly 
rare in patients from sub-Saharan Africa. Large-duct PSC, which 
is often associated with IBD, has been described in black people 
from South Africa. To our knowledge small-duct PSC has not been 
described in this population.
Case 1: A 26-year-old black woman with chronic diarrhoea, 
abdominal and back pain, was found to have Crohn’s disease 
involving the ascending colon and terminal ileum. No evidence of 
an axial arthropathy was found, and her HLA B27 was positive. 
Persistently elevated ALP and GGT were investigated. MRCP was 
normal. Liver biopsy showed small-duct PSC. 
Case 2: A 44-year-old black woman with chronic diarrhoea was 
found to have pan-colitis, ileitis and peri-anal fistula, compatible 
with Crohn’s disease. HLA B27 was positive. Persistently raised 
ALP and GGT were noted. MRCP was normal. Liver biopsy 
showed small-duct PSC. 
discussion: We present 2 cases of Crohn’s disease, which are 
unusual as:
•   Crohn’s disease is rare in black people in South Africa.
•   HLA B27 is rare in black people from sub-Saharan Africa.
•    Small-duct PSC has not yet been described in this population.
ChRonIC lIvER dISEASE IS A CoMMon PRoBlEM In 
SoUTh AfRICA
Chopdat n, Ally R, Klipin M, Sparaco A
Background: Chronic liver disease is a common problem in South 
Africa. Liver transplantation provides a therapeutic modality for 
patients who have end-stage liver disease and are eligible. A lack 
of resources in the public sector means that few patients can be 
offered this modality.
Aim: The aim of this study was to review the spectrum of liver 
pathology from a specialised liver clinic and identify patients who 
would be eligible for transplantation.
Methods: From our database of patients at the liver clinic at Chris 
Hani Baragwanath Hospital, Soweto, patients were assessed 
for criteria for eligibility. The criteria included South African 
nationality, age less than 40, HIV negative, and a MELD score 
greater than 6. 
Results: Over 12 months, 109 patients had been seen; 2 died, and 
1 has been transplanted. Of these 106, 58 are male (55%) and 48 
female (45%).
The age distribution is 6.6% under the age of 20, 37% under 40, 
23% under 50 and 34% older than 50.
The majority of liver disease is cryptogenic cirrhosis (23%), then 
auto-immune-related diseases (16%), chronic hepatitis B (12.3%), 
alcohol (11.3%) and schistosomiasis (11.3%). 
20 patients fulfilled the criteria (14 females, 6 males). MELD 
scoring revealed 5 patients with scores greater than 15 and 1 
greater than 20.
Conclusion: In this small cohort of patients one-fifth were eligible 
for liver transplantation, suggesting a need for a liver transplant 
unit in the public sector.
InITIAl ExPERIEnCE WITh lAPARoSoPIC dISTAl 
PAnCREATECToMy
devar J, Anderson f, loots E, Thomson S R
Introduction: Small cystic and neuro-endocrine pancreatic tumours 
are ideal cases for surgeons with advanced laparoscopic skills to 
initiate their experience with distal pancreatic resections. We report 
2 such cases. 
Patients: Case A. 60-year-old woman being investigated for 
epigastric pain had a 5×3 cm cystic lesion in the tail of the 
pancreas. CT and endosonar characterisation failed to establish a 
diagnosis. Case B. A 29-year-old truck driver was diagnosed with 
a 2 cm insulinoma localised on CT and endosonar to the mid-
pancreatic body. 
Technique: A secure Lloyd Davies position was used. The surgeon 
stood between the legs. A peri-umbilical visiport was used for 
access and as the primary 300 optical port. 10 - 12 mm trocars 
were placed in the left paraxiphoid, right mid-axillary line, and 
left anterior axillary line. Dissection was with hook, ultrasonic 
and blunt dissectors. The gastrocolic omentum was opened below 
the gastro-epiploic arch to expose the inferior margin of the 
pancreas to the left of the middle colic. The plane was extended 
superiorly under the pancreas, identifying and isolating the splenic 
vein. Dissection at the superior border of the pancreas identified 
and isolated the splenic artery. In case A the splenic vein was 
adherent to the tumour, and a distal pancreatectomy with an en 
bloc splenectomy was performed. Artery, vein and pancreatic 
parenchyma were divided with a vascular endostapler. The 
spleen was mobilised by sectioning the suspending ligaments and 
dividing the short gastric vessels. The specimen was then removed 
by extending the left upper quadrant port incision. In case B the 
vein and artery were easily separated from the pancreas and the 
spleen was preserved.
Results: The hospital stays were 11 and 3 days, respectively. 
There were no pancreatic complications. Histopathology of case A 
revealed a cystic mucinous neoplasm, and case B an insulinoma. 
Both were euglycaemic and well 3 months after resection. 
Conclusion: Laparoscopic distal pancreatic resection is safe for 
selected small neoplasms of the pancreas.
SolId PSEUdoPAPIllARy TUMoURS of ThE PAnCREAS
frost M, Bornman P C, Krige J E J, Panieri E P
Background and objective: Solid pseudopapillary tumours (SPT) 
of the pancreas are rare, low-grade malignant but curable tumours 
Poster Presentations
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that occur almost exclusively in young women. The clinical 
characteristics and surgical strategy in 20 patients with SPT of the 
pancreas are discussed. 
Methods: We report a retrospective review of 20 patients with 
SPT from patients treated over a 30-year period. Each case was 
evaluated with respect to age, sex, common presenting symptoms 
and signs, type of operation, histology and tumour markers, 
postoperative complications and follow-up. 
Results: All 20 patients were female. The average age was 24.6 
years (range 13 - 51). Fifteen patients presented with abdominal 
pain and 14 had a palpable abdominal mass on examination. Of the 
20 patients, 5 had a pylorus-preserving pancreaticoduodenectomy 
and the remainder had local excision or required a central or distal 
pancreatectomy. One patient had two liver metastases that were 
resected in addition to the pancreatic primary lesion. One patient 
died of multisystem organ failure. Other significant complications 
included bleeding (2) requiring re-operation and intra-abdominal 
fluid collections requiring percutaneous drainage (3) or operation 
(1).
Conclusion: Solid pseudopapillary tumours of the pancreas should 
be considered in young females presenting with abdominal pain 
and a large pancreatic mass. Complete resection is curative in most 
patients and metastases are rare. 
vATS AT SEBoKEnG hoSPITAl: InITIAl ExPERIEnCE
Isakov R, Koto M z
Introduction: VATS has been used in a variety of settings, with 
minimal morbidity and mortality. We document our initial 
experience at Sebokeng Hospital.
Method: Over the period 1/5/2006 to 13/5/2010, we collected 
records of patients who had undergone VATS at Sebokeng Hospital 
and Clinix Private Hospital. Demographics, clinical indication, 
operative findings, outcome and complications were looked at. The 
procedure was done under general anaesthetic, using single-lung 
ventilation (except 8-month-old patients).
Results: Over a period of 48 months 19 male and 6 female patients 
underwent VATS. The average age was 36 years (range 8 months - 
69 years).
Indications for VATS included: 
•    Trauma: non-resolving haemo/pneumothorax, empyema, 
foreign body retention
•   Pleural and lung biopsy
•   Pneumonic complication
•   Mediastinal mass
•   Cervical sympathectomy for hyperhidrosis.
Complications included 1 patient who was converted to open 
thoracotomy because of extensive adhesions and 2 patients with 
incomplete lung expansion. One patient required transfusion; 
recovery was otherwise uneventful. There were no deaths.
Conclusion: VATS is a viable and safe option for clotted 
haemothorax and decortications as well as many other indications. 
Early intervention is advised to avoid complications.
lAPARoSCoPIC hEllER MyoToMy foR AChAlASIA – 
oUR InTIAl ExPERIEnCE In A non-TERTIARy CEnTRE
Koto z, nteo S, Peraza l
Introduction and aim: Laparascopic Heller myotomy for achalasia 
has demonstrated beyond doubt that it is the best way to deal with 
this problem. The often cited advantages are better visualisation, 
minimal morbidity and early recovery. These procedures are 
largely done in tertiary centres. We document our initial experience 
of this procedure outside a tertiary centre.
Methods: The records of patients with documented achalasia 
who underwent laparoscopic Heller myotomy were prospectively 
collected between January 2005 and April 2010. The demographic 
data, clinical presentation, investigations, surgical procedure and 
outcome were looked at.
Results: Eleven patients were included in the analysis (6 males 
and 5 females), average age 32 years (23 - 45 years). The presenting 
symptoms were predominantly dysphagia and chest pain. All 
patients had gastroscopy and barium swallow. Some patients had 
manometry when available. Laparascopic Heller myotomy with an 
anti-reflux procedure was done in most cases. All patients reported 
significant improvement in their swallowing except 1 patient with 
an anterior dhor who had some discomfort with swallowing but 
eventually improved. No perforation or mortality was reported.
Conclusion: Laparascopic Heller myotomy is feasible and safe as a 
treatment option for achalasia, even outside tertiary centres.
ERCP EvolUTIon By CoMPARATIvE AUdIT AnAlySIS of 
TWo AUdIT PERIodS 4 yEARS APART
Mjoli M, Chinnery G, ferndale l, Govindasamy v,  
Thomson S R
Introduction: Endoscopic retrograde cholangio-pancreatography 
(ERCP) services were commenced at Grey’s Hospital in 2002. Our 
ERCP service is now established. In this audit we review our recent 
experience and compare it with the database during the years of its 
establishment.
Materials and methods: A retrospective review of a prospective 
database was analysed. All ERCPs performed during the years 
2008 and 2009 were reviewed and compared with the database of 
the first 2 years of establishment from 2002 to 2004. Two hundred 
and one and 379 ERCPs were performed in the respective periods. 
Results: The total number of cases has almost doubled from 201 to 
379. The mean age was 55.4 and the male/female ratio was 1:1.53; 
both were comparable between the two periods.  The 2008 - 2009 
period showed an increase in the proportional representation of 
malignant strictures, up from 39% to 42%. The overall cannulation 
rate has decreased from 92.5% to 78.3%, and this has been more 
pronounced for malignant strictures. The procedural failure rate 
for both stones and malignant strictures has significantly increased 
between the two study periods. No deaths occurred in 2008 - 2009 
compared with 7% in 2002 - 2004.
Conclusion: Annual volume has doubled. Malignant disease 
forms an increasing part of our ERCP practice. The morbidity and 
mortality rates have improved. The overall initial cannulation rate 
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and procedural success rate have decreased. More detailed analysis 
of case mix and the effect of a well-developed interventional 
radiological service on overall therapeutic success is required. 
BIlIARy ASCARIS CAUSInG ACUTE PAnCREATITIS – A 
CASE REPoRT
naidoo v G
Introduction: Pancreatitis is a rare but well-documented 
complication of Ascaris lumbricoides infestation. Diagnostic and 
therapeutic strategies to manage biliary ascaris are not well 
defined.
Case presentation: A 17-year-old man was referred to our unit 
following two episodes of pancreatitis without discernable 
cause. The liver enzymes were normal and a transabdominal 
ultrasound suggested a possible common bile duct (CBD) lesion. 
Endosonar revealed a hyperechoic mass within the CBD without 
accompanying acoustic shadow. Biliary ascaris was considered 
the most likely diagnosis. Endoscopic retrograde cholangiography 
confirmed a linear filling defect in the CBD and following 
sphincterotomy a 30 cm worm was extracted per os using a 
combination of an extraction balloon and dormia basket. The 
patient was subsequently treated with albendazole and made an 
uneventful recovery. No further episodes of pancreatitis symptoms 
were reported at review 1 month later.
discussion: Transabdominal ultrasound diagnosis of biliary ascaris 
requires a high level of expertise. Endosonar provides excellent 
definition of the CBD and may prove a useful additional diagnostic 
tool in such cases prior to endoscopic therapy. Most cases can be 
managed medically, with endoscopic therapy or surgery being 
restricted to specific clinical situations. The best clinical practice 
method of endoscopic worm extraction has not been defined, 
but avoidance of sphincterotomy is recommended owing to 
concern about facilitating worm migration in the event of future 
re-infestation. 
Conclusion: Ascaris infestation is endemic in South Africa. This 
case report highlights an important complication that may be 
encountered by gastro-enterologists and surgeons. Rapid diagnosis 
using available tools, selecting an appropriate management 
strategy and good follow-up usually results in a satisfactory clinical 
outcome.
PPARγ IS SIGnIfICAnTly REdUCEd In ColoRECTAl 
CAnCER CoMPAREd WITh InflAMMAToRy BoWEl 
dISEASE And IRRITABlE BoWEl SyndRoME 
M  ngaira, E fredericks, E Shivji, S Williams, G dealtry,  
S Roux
Background: Colorectal cancer is the 4th most common cause 
of cancer death. The early stages of carcinogenesis are poorly 
understood. Identification of appropriate target genes and their 
downstream effects is important in the early detection of colon 
carcinogenesis and to develop appropriate intervention at the 
molecular level. Variation in mRNA in tissue biopsies indicating 
changes in gene expression can be analysed by quantitative reverse 
transcription PCR (qRT-PCR). PPARγ and SREBP are important 
transcription factors involved in the regulation of inflammation 
and cellular differentiation. 
Aim: To compare expression of PPARγ and SREBP in colon biopsies 
from screening colonoscopy, irritable bowel syndrome (IBS), 
inflammatory bowel disease (IBD) and CRC. 
Methods: mRNA was extracted from colon biopsies, stored in 
RNALater (Ambion, USA) and reverse transcribed to cDNA. The 
relative expression patterns of PPARγ and SREBP were determined 
using gene-specific primers and changes in specific gene expression 
between samples were normalised with reference to two sets of Alu 
repeats and one stably expressed reference gene. 
Results: Expression of PPARγ in 80 biopsy samples showed clear 
differences between normal patients and those with colorectal 
pathology.  Relative expression of PPARγ was significantly reduced 
in samples from patients with CRC (5-fold) compared with patients 
in the normal screening colonoscopy group (p<0.01). Furthermore, 
relative expression of PPARγ in biopsies from patients with CRC 
was reduced 3-fold compared with all other patients (IBD and 
IBS) (p<0.005). In contrast, no significant change in the relative 
expression of SREBP was found. 
Conclusion:  Expression of PPARγ was downregulated in all colon 
pathologies and further downregulated in colon cancer, whereas 
expression of SREBP, an upstream transcription factor, remained 
unchanged. This confirms the central role of PPARγ in colon 
carcinogenesis and indicates regulation by an SREBP-independent 
mechanism. 
AIdS PERInEUM
Tun M 
Aim: To study perineal manifestations of AIDS.
Method: The study period was from 2000 to 2010. Patients from 
Lesedi Hospital were recruited. Patients who had AIDS and 
were treated by the author were included. All received standard 
treatment for AIDS.
Results: Fifty-eight patients (28 males and 30 females), mean age 
30.5 years (range 22 - 44), were included. Follow-up ranged from 
2 weeks to 6 years. Symptoms were proctalgia (35), soiling (50), 
bleeding (6) and lumps (6). Every patient underwent EUA of 
the perineum. The findings were multiple fistulas (35), peri-anal 
abscesses (7), anal ulcers (27), prolapsed haemorrhoids (5) and 
poor anal tone (49). The treatments were local steroid injection (4), 
colostomy (2), fistulotomy (10), I&D (4), HAART (50) and biopsy 
(48). Thirty-eight patients died during follow-up. Biopsies revealed 
mycobacterium (6), CMV (1) and nonspecific (41). Fifteen had 
proctalgia improved (none received local steroid injection), 12 had 
soiling improved, 17 had sepsis healed and 8 had persistent soiling 
(7 had fistulotomy with 1 non-healing wound) in the survivors. All 
patients with CMV and mycobacterium infections died.
Conclusion: Perineal manifestations reflect AIDS and urgent need 
for HAART. Concomitant CMV and mycobacterium infections 
predict poor outcome. Only patients who responded well to 
HAART had a good outcome.
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PREvAlEnCE of BACTERIAl InfECTIon In non-
CIRRhoTIC vARICEAl BlEEdInG PATIEnTS AT MAPUTo 
CEnTRAl hoSPITAl, MozAMBIQUE
van der Merwe S, Cunha l, Modcoicar P
Introduction: Bacterial translocation and sepsis often occur in 
chronic liver disease, leading to decompensation of liver function.
In patients with liver cirrhosis presenting with variceal bleeding, 
bacterial infections are particularly common. In fact 50% of CLD 
with variceal bleeding will have culture-positive infections that 
may directly impact on the outcome of therapy and mortality. 
This has led to the Baveno consensus recommending the use of 
antibiotics in the management of variceal bleeding. However, the 
prevalence and importance of bacterial infections in non-cirrhotic 
portal hypertension has not been studied
Aim: We studied the prevalence of bacterial infections in 
consecutive non-cirrhotic variceal bleeding patients.
Patients and methods: Patients with variceal bleeding were 
included in the study. At presentation blood and urine cultures 
were obtained, and the white cell count and CRP level were 
measured. Non-cirrhotic portal hypertension was confirmed by 
calculating the Child-Pugh score and excluding liver cirrhosis by 
means of sonography and appropriate serological tests.
Results: 31 patients were included in the study, of whom 71% 
(22/31) were male. Blood and urine cultures were positive in 29% 
(9/31) and 10% (3/31), respectively. Only 1 patient died during the 
hospital admission. 
discussion: The importance of bacterial sepsis in variceal bleeding 
due to non-cirrhotic portal hypertension remains unknown. Our 
study showed that culture-positive bacterial infections occurred 
in 29% of patients. This is substantially lower than described for 
cirrhotic liver disease. However, it still suggests that bacterial 
infections may affect the outcome of these patients, requiring 
the use of prophylactic antibiotic therapy in the management of 
variceal bleeding.
